Dynarex Povidone Iodine Prep Pads
100 Per Box
LIMIT 10 BOXES PER ORDER
Ideal for antiseptic skin preparation, venipuncture, IV starts, renal dialysis, pre-op prepping and other minor invasive procedures.
Each pad is saturated with 10% povidone iodine solution.
100 Per box
Visit our Soaps and Sanitizers category
Frequently Asked Questions
What is Povidone-Iodine?
Povidone, also known as polyvinylpyrrolidone (PVP), was originally developed as a plasma expander for trauma victims. Now it is commonly used in artificial tears and eye lubricating products. Some contact lens manufacturers even incorporate povidone into their lens to act as a wetting agent to increase moisture retention. Povidone is also used as a binder in controlled-release tablets and in liquid oral medications. You can frequently find it listed in cosmetic products such as hair spray, lipstick, gels, toothpaste, and shampoos.
Large ingestions of povidone are expected to cause only minimal symptoms such as diarrhea. If povidone gets into the eyes or onto the skin, it might cause irritation and pain. There have been reports of severe allergic reactions occurring in sensitive people, but this reaction is rare. Symptoms of a severe allergic reaction include wheezing; difficulty breathing; dizziness; chest tightness; hives; and swelling of the lips, face, tongue, or throat. If these symptoms occur, call 911 immediately regardless of the suspected cause.
When povidone is combined with iodine, it is most commonly used as an antiseptic for the skin in the form of povidone iodine prep pads (e.g., Betadine), but it can also be used in less concentrated forms for the eyes and vagina. Surgeons use povidone iodine prep pads to disinfect skin prior to surgery. The 10% solution is used most often to disinfect skin with povidone iodine prep pads, but it also comes in diluted concentrations as low as 0.3%.
Common side effects seen with both povidone-iodine eye drops and skin formulations include local swelling, irritation, itching, and rash. With overuse, povidone iodine prep pads can have corrosive effects. With eye exposures, patients should irrigate the eyes for 15 minutes immediately after an exposure. Any persistent eye pain or symptoms might need medical examination and treatment. Ingestion can cause stomach upset, vomiting, diarrhea, and burns of the gastrointestinal tract.
In excessive doses, there is a risk for iodine toxicity, which can lead to kidney failure, changes in electrolyte concentrations, or other organ failure. Toxicity is most commonly seen when topical povidone-iodine is used chronically and in large amounts.
Certain people (burn victims, pregnant women, patients with kidney dysfunction, and those with thyroid disorders) should speak with their healthcare provider prior to using povidone-iodine because they might be more sensitive to the effects of povidone-iodine.
If you suspect someone is having symptoms from a povidone overdose, check the webPOISONCONTROL® online tool for guidance or call Poison Control at 1-800-222-1222.
What skin preparation is done prior to surgery?
Procedural and surgical site infections create difficult and complex clinical scenarios. A source for pathogens is often thought to be the skin surface, making skin preparation at the time of the procedure critical. The most common skin preparation agents used today include products containing iodophors such as povidone iodine prep pads or chlorhexidine gluconate. Agents are further classified by whether they are aqueous-based or alcohol-based solutions. Traditional aqueous-based iodophors, such as povidone iodine prep pads, are one of the few products that can be safely used on mucous membrane surfaces. Alcohol-based solutions are quick, sustained, and durable, with broader spectrum antimicrobial activity. These agents seem ideal for longer open surgeries with the potential for irrigation or surgical spillage.
Surgical site infection (SSI) complicates an estimated 5% of all clean-contaminated operations performed annually in US hospitals and accounts for the most common nosocomial infection in surgical patients. Patients who develop SSI have longer and costlier hospitalizations and are more likely to spend time in an intensive care unit (ICU), are 5 times more likely to be readmitted, and are twice as likely to die.
Recognizing this substantial morbidity and economic burden, in 1999 the Centers for Disease Control (CDC) issued standardized guidelines for the prevention of surgical infections. These included making specific evidence-based recommendations for modifying patient factors that may predispose to infection, for the use of antimicrobial prophylaxis, for optimizing sterility in the operating room, and for the use of antiseptic agents such as povidone iodine prep pads for skin preparation.